Purpose: To evaluate the long-term urinary outcomes of men with severe pretreatment lower urinary tract symptoms (LUTS) treated with permanent prostate brachytherapy (PPB) ± external beam radiation therapy for localized prostate cancer.
Methods And Materials: A total of 105 men with International Prostate Symptom Score (IPSS) 20-35 before PPB were categorized by IPSS change at last followup: (1) worse = IPSS rise >3; (2) no change = IPSS change within three points of baseline; (3) improved = IPSS fall by >3 points. We then evaluated patients who worsened vs. those who did not (no change or improved) with respect to incontinence outcomes, LUTS medication usage, and predictors of symptom worsening.
Results: Mean followup was 80.3 ± 55.8 months. Mean age was 66.3 ± 7.1 years; mean pretreatment IPSS was 23.6 ± 3.0. Overall mean improvement in IPSS was 7.6 ± 9.3. Specifically, 14.3% (15/105) worsened, 21.9% (23/105) had no significant change, and 63.8% (67/105) improved. There were no patient- or treatment-related factors significantly associated with long-term worsening of urinary symptoms. No men required anticholinergic therapy at last followup, whereas 7% (8/105) were using an alpha blocker. Only 2.9% (3/105) of men were using at least one pad daily at last followup. Alternatively, only 7.7% (8/105) reported subjective incontinence.
Conclusions: PPB is an acceptable option in the setting of severe baseline LUTS in appropriately selected and counseled patients when performed by a skilled practitioner.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.brachy.2019.02.002 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Haralick texture feature analysis for Monte Carlo dose distributions of permanent implant prostate brachytherapy.
Brachytherapy
January 2025
Carleton Laboratory for Radiotherapy Physics, Physics Department, Carleton University, Ottawa, ON, Canada. Electronic address:
Purpose: Demonstrate quantitative characterization of 3D patient-specific absorbed dose distributions using Haralick texture analysis, and interpret measures in terms of underlying physics and radiation dosimetry.
Methods: Retrospective analysis is performed for 137 patients who underwent permanent implant prostate brachytherapy using two simulation conditions: "TG186" (realistic tissues including 0-3.8% intraprostatic calcifications; interseed attenuation) and "TG43" (water-model; no interseed attenuation).
Prostatic Artery Embolization: Mid- to Long-Term Outcomes in 1,075 Patients.
J Vasc Interv Radiol
November 2024
Desai Sethi Urology Institute, University of Miami, Miller School of Medicine, Miami, Florida.
Purpose: To assess the mid- to long-term safety and effectiveness of prostatic artery embolization (PAE) at a single-center cohort of 1,075 patients.
Materials And Methods: This institutional review board-approved retrospective study included patients with moderate-to-severe lower urinary tract symptoms (LUTS) or urinary retention who underwent PAE from January 2014 to July 2023. Patients were assessed at 1, 3, 6, and 12 months after PAE and yearly thereafter.
Predictors of corporo-venocclusive dysfunction in men with bilateral nerve-sparing radical prostatectomy.
J Sex Med
January 2025
Sexual & Reproductive Medicine Program, Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States.
Article Synopsis
- Erectile dysfunction (ED) can occur in men who have had bilateral nerve-sparing surgery, with corporo-venocclusive dysfunction (CVOD) being a primary cause of permanent ED after radical prostatectomy (RP).
- A study examined comorbidity factors linked to CVOD in men without prior ED who underwent RP, finding significant associations with increased age and obstructive sleep apnea (OSA).
- The research highlights that comorbidities, particularly OSA, influence recovery of erectile function post-surgery; however, the findings may not apply broadly to all patients, as the study focused on men already seeking treatment for ED.
Current status of the working environment of brachytherapy in Japan: a nationwide survey-based analysis focusing on radiotherapy technologists and medical physicists.
J Radiat Res
December 2024
Department of Radiology, University of Yamanashi Faculty of Medicine, 1110 Shimokato, Chuo-shi, Yamanashi 409-3898, Japan.
Article Synopsis
- Brachytherapy (BT), particularly high dose rate (HDR) BT, has become more complex due to advanced techniques, necessitating significant training for radiotherapy technologists and medical physicists (RTMPs).
- A survey conducted across 837 radiation treatment facilities in Japan revealed varying working times for HDR procedures and low quality control (QC) implementation rates for BT compared to external beam radiation therapy (EBRT).
- The findings underscore a need for improved training and education for RTMPs to enhance the quality and safety of BT practices in Japan.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!